Beneficial effects of naringenin in liver diseases: Molecular mechanisms.

about

Role of secretory clusterin in hepatocarcinogenesis

P2860

Q58804368-5DD697B0-9B21-4F6E-B9E3-08538803F3B4

P2860

Beneficial effects of naringenin in liver diseases: Molecular mechanisms.

Item

http://www.wikidata.org/entity/Q54113356

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

Beneficial effects of naringenin in liver diseases: Molecular mechanisms.

@en

Beneficial effects of naringenin in liver diseases: Molecular mechanisms.

@nl

type

Item

label

Beneficial effects of naringenin in liver diseases: Molecular mechanisms.

@en

Beneficial effects of naringenin in liver diseases: Molecular mechanisms.

@nl

prefLabel

Beneficial effects of naringenin in liver diseases: Molecular mechanisms.

@en

Beneficial effects of naringenin in liver diseases: Molecular mechanisms.

@nl

P1476

Beneficial effects of naringenin in liver diseases: Molecular mechanisms.

@en

P2093

Erika Hernández-Aquino

http://www.w3.org/2001/XMLSchema#string

Pablo Muriel

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution-NonCommercial 4.0 License

P2860

Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010

Free radicals and antioxidants in normal physiological functions and human disease

hCTR1: a human gene for copper uptake identified by complementation in yeast

NAADP mobilizes calcium from acidic organelles through two-pore channels

Mechanisms pertaining to arsenic toxicity

Naringenin prevents dyslipidemia, apolipoprotein B overproduction, and hyperinsulinemia in LDL receptor-null mice with diet-induced insulin resistance

Nrf2 is a direct PERK substrate and effector of PERK-dependent cell survival

Metabolic derivatives of alcohol and the molecular culprits of fibro-hepatocarcinogenesis: Allies or enemies?

Reversible Human TGF-β Signal Shifting between Tumor Suppression and Fibro-Carcinogenesis: Implications of Smad Phospho-Isoforms for Hepatic Epithelial-Mesenchymal Transitions

Evaluation and management of lead exposure

P304

1679-1707

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P356

10.3748/WJG.V24.I16.1679

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

2018-04-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29713125

http://www.w3.org/2001/XMLSchema#string

P921

mechanism of action

liver disease

Amathumbu

P932

5922990

http://www.w3.org/2001/XMLSchema#string

Beneficial effects of naringenin in liver diseases: Molecular mechanisms.

about

P2860

P2860

Beneficial effects of naringenin in liver diseases: Molecular mechanisms.

description

name

type

label

prefLabel

P1433

P1476

P2093

P275

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921

P932

P356

P1433

P1476

P2093

P275

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921

P932